Pacira Pharmaceuticals: Choices Matter – An In-Depth Analysis of the Opioid Epidemic and Overprescribing in America

Pacira Pharmaceuticals, a pharmaceutical company, showed US women the dangers of opioids after surgery by launching national research and revealing the data findings via an advocacy event and microsite.

Situation Analysis

The opioid epidemic is the deadliest drug crisis in U.S. history, killing nearly 72,000 Americans in 2017 alone. These startling numbers succinctly validate why the opioid epidemic has dominated the news. The media's interest in the opioid crisis has remained steadfast, and while some data shows marginal decreases in opioid use, it's clear this is still a debilitating issue. Further, the conversation neglected to focus on a main driver of persistent opioid use – surgery had become an inadvertent gateway to opioid addiction and dependence.

To be credible in the healthcare space, data is paramount. Pacira Pharmaceuticals, an...

WARC subscribers can sign in to keep reading

Not a subscriber?

Schedule your live demo with our team today

WARC helps you to plan, create and deliver more effective marketing

  • Prove your case and back-up your idea

  • Get expert guidance on strategic challenges

  • Tackle current and emerging marketing themes

We’re long-term subscribers to WARC and it’s a tool we use extensively. We use it to source case studies and best practice for the purposes of internal training, as well as for putting persuasive cases to clients. In compiling a recent case for long-term, sustained investment in brand, we were able to support key marketing principles with numerous case studies sourced from WARC. It helped bring what could have been a relatively dry deck to life with recognisable brand successes from across a broad number of categories. It’s incredibly efficient to have such a wealth of insight in one place.

Insights Team
Bray Leino

You’re in good company

We work with 80% of Forbes' most valuable brands* and 80% of the world's top top-of-the-class agencies.

* Top 10 brands